{
    "nctId": "NCT02222259",
    "briefTitle": "A Feasibility Trial of Geriatric Assessment and Management for Older Cancer Patients",
    "officialTitle": "A Feasibility Trial of Geriatric Assessment and Management for Older Cancer Patients (A GEM Study for Older Cancer Patients)",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Gastrointestinal Cancer, Genitourinary Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "Quality of life",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Clinical diagnosis of advanced (stage 2, 3 or 4) Gastrointestinal, Genitourinary, or breast cancer\n* Referred for first-line chemotherapy\n* Ability to speak English\n* Physician estimated life expectancy \\>6 months\n* An Eastern Oncology Group Collaborative (ECOG) Performance Score of 0-2\n* Ability to provide informed consent\n\nExclusion Criteria:\n\n* Previous chemotherapy for current stage of disease",
    "sex": "ALL",
    "minimumAge": "70 Years",
    "stdAges": "OLDER_ADULT"
}